2026 Antimicrobial Peptide Conference
Antimicrobial Peptides: Yesterday, Today and Tomorrow II
Registration is open for the second antimicrobial peptide conference, a free, one-day Zoom event on Oct. 19. The conference includes presentations from leading figures in antimicrobial peptide research from around the world.
Schedule
Welcoming remarks: 8 am, Dr. Joseph Khoury, professor and chair of the UNMC Department of Pathology, Microbiology and Immunology
Session I: Discovery, design and applications of AMPs
- 8:15 to 8:45 am, TBA
- 8:45 to 9:15 am, Colin Hill (University College Cork, Ireland), Bacterial lantibiotics as antibiotics?
- 9:15 to 9:45 am, Maria Luisa Mangoni (Universita La Sapienza, Italy), European amphibian AMPs: Discovery and applications
- 9:45 to 10:15 am, Karin Thevissen (Centre of Microbial and Plant Genetics, Belgium), Plant defensins: Discovery and applications
Morning break: 10:15 to 10:30 am
Session II: History of antimicrobial peptide discovery
- 10:30 to 11 am, Michael Zasloff (Georgetown University, USA), My discovery of magainins and their translational research experiences
- 11 to 11:30 am, Tomas Ganz (University of California Los Angeles, USA), The discovery of human alpha-defensins
- 11:30 am to noon, Chuck Bevins (University of California Davis, USA), Human defensins and its role in microbiota
- Noon to 12:30 pm, Robert Hancock (University of British Columbia, Canada), Host defense peptides: My perspective
Lunch break: 12:30 to 1 pm
Session III: AI prediction of antimicrobial peptides
- 1 to 1:30 pm, Octavio Luiz Franco (Universidade Catolica Dom Bosco, Brazil), In silico discovery of antimicrobial peptides
- 1:30 to 2 pm, Monique van Hoek (George Mason University, USA), Peptide sensing and phenotypic escape: D-GATR-3, GraRS and Trailing Susceptibility in MRSA
- 2 to 2:30 pm, Cesa de la Fuente (University of Pennsylvania, USA), Accelerating antibiotic discovery with AI
- 2:30 to 3 pm, Inanc Birol (University of British Columbia, Canada), Deep learning prediction of antimicrobial peptides
Afternoon break: 3 to 3:15 pm
Session IV: Peptide drugs for challenging diseases
- 3:15 to 3:45 pm, Michael E. Selsted (University of Southern California, USA), Theta-defensins from mammals
- 3:45 to 4:15 pm, William Shafer (Emory University, USA), Gonorrhea, AMPs and decreased susceptibility mechanisms impacting clinically used antibiotics
- 4:15 to 4:45 pm, Hicks Leslie (University of North Carolina at Chapel Hill, USA), MS discovery of natural AMPs
- 4:45 to 5:15 pm, David Craik (The University of Queensland, Australia), Discovery of cyclotides as peptide therapeutics
Closing remarks: 5:15 pm